CCR2 and neoplasm: For instance, systemic administration of CCL2-neutralizing antibodies in tumor-bearing mice or the short-hairpin RNA knockdown of CCR2 in the cancer cell lines significantly reduced tumor growth along with reduced TAM recruitment [21].